JV

Jeegarsinh Vishnubhai Zala

Active Director Director DIN 11532886
DIN 11532886 First appointment Feb 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Jeegarsinh Vishnubhai Zala

Data last updated:

Jeegarsinh Vishnubhai Zala is a Director at Melayurveda (India) Private Limited (since 2026). The company operates in Healthcare.

DIN 11532886
Primary Designation Director
Industry Healthcare
First Appointment 08 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Melayurveda (India) Private Limited U47720GJ2026PTC173245
Director08 Feb 20262026Active

Board colleagues of Jeegarsinh Vishnubhai Zala

NameDINCompanyDesignation
Haresh Arjanbhai Kalotra11532885Melayurveda (India) Private LimitedDirector

Directorship timeline

Open interactive timeline →
Melayurveda (India) Private Limited
Premium access

Shareholding and investment profile for Jeegarsinh Vishnubhai Zala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeegarsinh Vishnubhai Zala

Jeegarsinh Vishnubhai Zala currently holds 1 directorship: Melayurveda (India) Private Limited (Director, since 08 Feb 2026).

Jeegarsinh Vishnubhai Zala was first appointed on 08 Feb 2026 as Director at Melayurveda (India) Private Limited.

The current boards of Jeegarsinh Vishnubhai Zala's companies include Haresh Arjanbhai Kalotra (Melayurveda (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available